Biobank for "Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment"
"Arrhythmia and Conduction Disorders: TowArd Pathophysiology Based Treatment" ADAPT Biobank
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1,000 participants
Dec 18, 2014
OBSERVATIONAL
Conditions
Summary
The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis. Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04776642